Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis

Journal of Hepatology

Volumn 44, Issue 6, 2006, Pages 1208-1212

  Bihl, Florian ^a   Emmenegger, Urban ^b   Reichen, Jürg ^c   Neftel, Klaus A ^d   Zimmermann, Arthur ^c   Cerny, Andreas ^a,c  

^a Ospedale Civico Lugano   (Switzerland)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c UNIVERSITY OF BERN   (Switzerland)

^d Spital Bern Ziegler ^*  (Switzerland)

Author keywords

CD8+ cells; Cholestasis; Ductopenia; Hodgkin's lymphoma; Kupffer cells; Macrophage activating syndrome (MAS); NK cells; Non Hodgkin's lymphoma; T cells; Vanishing bile duct syndrome

Indexed keywords

CD8 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VINCRISTINE;

ADULT; AGED; ANAMNESIS; APOPTOSIS; ARTICLE; BILE DUCT INJURY; BONE MARROW APLASIA; BONE MARROW BIOPSY; CASE REPORT; CHOLESTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HEMATOLOGIC DISEASE; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LIVER BIOPSY; LIVER CELL; LIVER TRANSPLANTATION; LOW DRUG DOSE; MACROPHAGE; MACROPHAGE ACTIVATING SYNDROME; MALE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; BILE DUCT DISEASES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HEMATOLOGIC DISEASES; HEPATITIS; HUMANS; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MIDDLE AGED; SYNDROME;

EID: 33646485697     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.03.003     Document Type: Article

References (17)

1. Henter J.I., Elinder G., and Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL study group of the histiocyte society. Semin Oncol 18 (1991) 29-33
2. Emmenegger U., Schaer D.J., Larroche C., and Neftel K.A. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 135 (2005) 299-314
3. Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 66 (1997) 135-151
4. Janka G., Imashuku S., Elinder G., Schneider M., and Henter J.I. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin N Am 12 (1998) 435-444
5. Fisman D.N. Hemophagocytic syndromes and infection. Emerg Infect Dis 6 (2000) 601-608
6. Zimmermann A., Gloor B., Kappeler A., Uhl W., Friess H., and Buchler M.W. Pancreatic stellate cells contribute to regeneration early after acute necrotising pancreatitis in humans. Gut 51 (2002) 574-578
7. Tran A., Housset C., Boboc B., Tourani J.M., Carnot F., and Berthelot P. Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments. J Hepatol 12 (1991) 36-39
8. Kikuchi K., Miyakawa H., Abe K., Fujikawa H., Horiuchi T., Nagai K., et al. Vanishing bile duct syndrome associated with chronic EBV infection. Dig Dis Sci 45 (2000) 160-165
9. Cervantes F., Briones J., Bruguera M., Font C., Grau J.M., Rozman C., et al. Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients. Ann Hematol 72 (1996) 357-360
10. Hubscher S.G., Lumley M.A., and Elias E. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hepatology 17 (1993) 70-77
11. Takahashi N., Chubachi A., Kume M., Hatano Y., Komatsuda A., Kawabata Y., et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 74 (2001) 209-213
12. Favara B.E. Histopathology of the liver in histiocytosis syndromes. Pediatr Pathol Lab Med 16 (1996) 413-433
13. Tsui W.M., Wong K.F., and Tse C.C. Liver changes in reactive haemophagocytic syndrome. Liver 12 (1992) 363-367
14. de Kerguenec C., Hillaire S., Molinie V., Gardin C., Degott C., Erlinger S., et al. Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases. Am J Gastroenterol 96 (2001) 852-857
15. Billiau A.D., Roskams T., Van Damme-Lombaerts R., Matthys P., and Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. Blood 105 (2005) 1648-1651
16. Emmenegger U., Zehnder R., Frey U., Reimers A., Spaeth P.J., and Neftel K.A. Elevation of soluble Fas and soluble Fas ligand in reactive macrophage activation syndromes. Am J Hematol 64 (2000) 116-119
17. Wiesner R.H., Ludwig J., van Hoek B., and Krom R.A. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology 14 (1991) 721-729